Accuray Incorporated Total Liabilities
Accuray Incorporated total liabilities. Based on the latest financial reports, Accuray Incorporated (ARAY) has total liabilities worth $401.98 Million USD as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check Accuray Incorporated (ARAY) asset resilience to evaluate the company's liquid asset resilience ratio.
Total Liabilities of Accuray Incorporated (2002–2026)
Total liabilities of Accuray Incorporated from 2002 to 2026. This chart illustrates how Accuray Incorporated's total liabilities have evolved over time, based on quarterly financial data. Explore ARAY long-term asset investment ratio to see how much of total assets are deployed in long-term investments.
Accuray Incorporated Competitors by Total Liabilities
The table below lists competitors of Accuray Incorporated ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Libet S.A.
WAR:LBT
|
Poland | zł22.31 Million |
|
Rich Sparkle Holdings Limited Ordinary Shares
NASDAQ:ANPA
|
USA | $2.85 Million |
|
Alphawave IP Group PLC
LSE:AWE
|
UK | GBX657.59 Million |
|
Leeuwin Metals Ltd
AU:LM1
|
Australia | AU$2.08 Million |
|
Aqua Corporation Public Company Limited
BK:AQUA
|
Thailand | ฿3.40 Billion |
|
CHARWOOD ENERGY EO -01
F:L5Q
|
Germany | €13.81 Million |
|
Serina Therapeutics Inc
NYSE MKT:SER
|
USA | $10.82 Million |
|
Bactiquant AS
CO:BACTIQ
|
Denmark | Dkr10.81 Million |
Liability Composition Analysis (2002–2026)
This chart breaks down Accuray Incorporated's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see Accuray Incorporated assets under control.
Liquidity & Leverage Metrics
Accuray Incorporated Total Liabilities Ratios Explained
Accuray Incorporated total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.50 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 9.64 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.91 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Accuray Incorporated's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Accuray Incorporated (2002–2026)
The table below shows the annual total liabilities of Accuray Incorporated from 2002 to 2026.
| Year | Total Liabilities | Change |
|---|---|---|
| 2026-06-30 | $401.98 Million | +3.32% |
| 2025-06-30 | $389.07 Million | -8.14% |
| 2024-06-30 | $423.54 Million | -0.47% |
| 2023-06-30 | $425.56 Million | +1.40% |
| 2022-06-30 | $419.66 Million | +2.04% |
| 2021-06-30 | $411.26 Million | -3.75% |
| 2020-06-30 | $427.29 Million | +10.04% |
| 2019-06-30 | $388.31 Million | +17.64% |
| 2018-06-30 | $330.10 Million | -8.29% |
| 2017-06-30 | $359.93 Million | -12.08% |
| 2016-06-30 | $409.37 Million | +3.85% |
| 2015-06-30 | $394.19 Million | -0.62% |
| 2014-06-30 | $396.64 Million | +7.46% |
| 2013-06-30 | $369.09 Million | +37.06% |
| 2012-06-30 | $269.30 Million | +24.99% |
| 2011-06-30 | $215.46 Million | +131.41% |
| 2010-06-30 | $93.11 Million | -22.72% |
| 2009-06-30 | $120.48 Million | -26.64% |
| 2008-06-30 | $164.24 Million | -20.53% |
| 2007-06-30 | $206.67 Million | -5.84% |
| 2006-06-30 | $219.48 Million | +53.45% |
| 2005-06-30 | $143.03 Million | +118.72% |
| 2003-06-30 | $65.39 Million | +83.92% |
| 2002-06-30 | $35.56 Million | -- |
About Accuray Incorporated
Accuray Incorporated engages in the design, development, manufacture, and sale of radiosurgery and radiation therapy systems for the treatment of tumors in the United States, Canada, Latin America, Asia, Australia, New Zealand, Europe, the Middle East, India, Africa, Japan, and China. The company offers the CyberKnife platform, a robotic stereotactic radiosurgery and stereotactic body radiation t… Read more